…the disease. Groupe de Recherche sur l’Arterite a Cellules Geantes. Ann Rheum Dis. 1999;58:335-341. https://doi.org/10.1136/ard.58.6.335 Gonzalez-Gay MA, et al. Giant cell arteritis: disease patterns of clinical presentation in a series…
Content Section:
Case Reports
Quanterix Granted Breakthrough Device Designation from U.S. FDA Blood-based assay has the potential to serve the multiple sclerosis (MS) community in management of relapsing-remitting form of the disease April 22,…
Content Section:
News Posts
…of cerebral disease delivered at the Royal College of Physicians [9]. Subsequent independent neuroanatomical studies of the experimental animals of both researchers indicated that Goltz’s lesions were not as extensive…
Content Section:
Articles
MND Webinar: Pain Management for motor neurone disease
Content Section:
Events
Motor Neurone Disease (MND) webinar: Equipment Solutions – your questions answered
Content Section:
Events
…with Disease-Modifying Therapies. CNS Drugs. 2021;35(3):317-330. doi:10.1007/s40263-021-00804-1 5. Möhn N, Konen FF, Pul R, et al. Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published…
Content Section:
News Posts
…loudness of voice in Parkinson’s). Mariella Graziano, Margarita Makoutonina and F Adib spoke on physiotherapy, the role of occupational therapy and special interst groups in Parkinson’s respectively. Several other sessions…
Content Section:
Conference Reports
Orodispersible film formulation of disease-modifying drug riluzole now available to ALS patients in the UK Emylif offers an alternative for the 80% of patients who experience difficulty swallowing during the…
Content Section:
News Posts